Related Experiment Video
Updated: Apr 7, 2026
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment
Elaine Taylor1, Duc Vu1, Carole Legare1
1Marketed Biologics, Biotechnologies and Natural Health Products Bureau, Marketed Health Products Directorate, Health Canada, Ottawa, Ontario, Canada.
Insights
Hemolysis is a rare risk with intravenous immune globulin (IVIG). This study compared two methods for identifying IVIG-associated hemolysis cases in Canada, finding case numbers varied by definition.
Area of Science:
- Pharmacovigilance
- Hematology
- Drug Safety
Background:
- Hemolysis is a rare but serious adverse event linked to intravenous immune globulin (IVIG) therapy.
- Accurate identification of these events is crucial for patient safety and understanding drug risks.
- This study examines case ascertainment methods for IVIG-associated hemolysis in Canada.
Purpose of the Study:
- To compare two distinct methods for identifying and confirming cases of hemolysis following IVIG administration.
- To analyze the trends in reported hemolytic reactions over a defined period.
- To assess the impact of different case definitions on reported adverse event numbers.
Main Methods:
- Retrospective analysis of adverse event reports submitted to Canada Vigilance between 2006 and 2012.
- Utilized standardized MedDRA queries for hemolytic disorders.
- Applied the Transfusion Transmitted Injuries Surveillance System (TTISS) algorithm for causality assessment and compared findings against the IVIG Hemolysis Pharmacovigilance Group case definition.
Main Results:
- Out of 942 IVIG adverse event reports, 313 (33%) involved hemolytic disorders.
- Using a modified TTISS definition, 226 cases were possibly related to IVIG; 69 met the stricter IVIG Hemolysis Pharmacovigilance Group definition.
- Reported "hemolytic disorder" cases did not correlate with the increasing distribution of IVIG over the study period.
Conclusions:
- The number of reported IVIG-associated hemolytic events fluctuated annually.
- The case definition employed significantly impacts the number of confirmed IVIG-associated hemolysis reports.
- Standardized case definitions are essential for consistent pharmacovigilance of IVIG adverse events.
Background:
Hemolysis is a rare adverse event associated with the use of intravenous immune globulin (IVIG). Using the Canadian experience, this article compares two methods used for case ascertainment of hemolysis after IVIG.
Study Design And Methods:
This is a retrospective, descriptive analysis of case reports of hemolytic reaction after exposure to IVIG. The cases were ascertained from the Canada Vigilance database using the standardized MedDRA query for hemolytic disorders between the years 2006 and 2012 inclusively. The presence of a causal relationship was determined by using the Transfusion Transmitted Injuries Surveillance System (TTISS) algorithm. Cases were then reviewed against the standardized case definition of IVIG-associated hemolysis proposed by the IVIG Hemolysis Pharmacovigilance Group.
Results:
A total of 942 adverse event reports after exposure to IVIG had been received by Canada Vigilance during the study period. A search for the adverse event of hemolytic disorder retrieved 313 reports (33%). Using a modified TTISS definition of hemolysis and the TTISS causality assessment algorithm, 226 cases were found to be at least possibly related to administration of IVIG, whereas 69 cases met the definition of the IVIG Hemolysis Pharmacovigilance Group. The amount of IVIG distributed increased over the study period; this trend was not reflected in the number of adverse reaction reports for "hemolytic disorder" received.
Conclusion:
The number of case reports per year received for the adverse event "hemolytic disorder" after exposure to IVIG fluctuated. The number of confirmed case reports varied depending on the case definition being used.
